Insider · CIK 0001825005
Andrew Combs
Files at PRLD (Prelude Therapeutics Inc). First filing Dec 26, 2024, latest Mar 27, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PRLD: Prelude Therapeutics Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 29Weak | PRLDbuy Prelude Therapeutics Inc | $69k 100,000 shares | +26% | - | |
| 45Moderate | Prelude Therapeutics Inc | $86k 63,075 shares | +20% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2025 | PRLD Prelude Therapeutics Inc | POpen-market purchase Common Stock | +100,000 | $0.69 | $69k | 480,123 | Mar 27, 2025 |
| Feb 4, 2025 | PRLD Prelude Therapeutics Inc | AGrant or award Employee Stock Option (right to buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Feb 5, 2025 |
| Dec 20, 2024 | PRLD Prelude Therapeutics Inc | POpen-market purchase Common Stock | +3,075 | $1.15 | $3,536 | 317,623 | Dec 26, 2024 |
| Dec 23, 2024 | PRLD Prelude Therapeutics Inc | POpen-market purchase Common Stock | +60,000 | $1.37 | $82k | 377,623 | Dec 26, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.